Stockwell Lynn insider trades
Stockwell Lynn has filed 8 Form 4s with the SEC that we hold, for BGXX (Director, 10% owner), Drugs Made In America Acquisition Corp. (DMAA) (CEO and Exe. Chair of Board, Director, 10% owner) and Drugs Made In America Acquisition II Corp. (DMII) (CEO and Exe. Chair of Board, Director, 10% owner). Across all of them we count 3 purchases worth $0 and 4 sales worth $477.5K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 1,000,000 shares of BGXX worth $360.0K, dated 2024-06-05. The first filing on our record is dated 2023-06-01 and the latest 2025-10-01.
BGXX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-31 | S, sale reported on Form 4 | 250,000 | $117.5K | 2023-09-06 |
| 2024-06-05 | S, sale reported on Form 4 | 1,000,000 | $360.0K | 2024-06-10 |
Drugs Made In America Acquisition Corp. (DMAA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-01-29 | S, sale reported on Form 4 | 5,698,363 | - | 2025-02-04 |
| 2025-01-29 | P, purchase reported on Form 4 | 400,000 | - | 2025-02-04 |
| 2025-02-18 | P, purchase reported on Form 4 | 30,000 | - | 2025-02-18 |
Drugs Made In America Acquisition II Corp. (DMII)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-09-26 | P, purchase reported on Form 4 | 700,000 | - | 2025-10-01 |
| 2025-09-26 | S, sale reported on Form 4 | 7,966,667 | - | 2025-10-01 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1927032) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms